Abstract
Objective
Non-cirrhotic intrahepatic portal hypertension (NCIPH), a portal microangiopathy affecting small portal vein radicles, is a disease of Indian sub-continent. NCIPH appears to be a complex disease with interactions between inherited and acquired factors, though the exact pathophysiological mechanism is unknown. We aimed at investigating the genetic variants that might contribute to susceptibility to NCIPH.
Methods
In this case-control study, we analyzed genes associated with microangiopathy—VWF-ADAMTS13 (von Willebrand factor and its cleavase enzyme — a disintegrin and matrix metalloprotease with thrombospondin type-1 motifs member 13) and alternative complement system vitamin B12 metabolism and with familial NCIPH.
Result
Eighty-four Indian patients with liver biopsy–proven NCIPH (cases) and 103 healthy controls (matched for residential region of India) were included in the study. Targeted next-generation sequencing (NGS) panel, comprising 11 genes of interest, was done on 54 cases. Genotyping of selected variants was performed in 84 cases and 103 healthy controls. We identified variants in MBL2, CD46 and VWF genes either associated or predisposing to NCIPH. We also identified a single case with a novel compound heterozygous mutation in MBL2 gene, possibly contributing to development of NCIPH.
Conclusion
In this first of a kind comprehensive gene panel study, multiple variants of significance have been noted, especially in ADAMTS13-VWF and complement pathways in NCIPH patients in India. Functional significance of these variants needs to be further studied.
Graphical abstract
Similar content being viewed by others
References
Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver. 1982;2:176–92.
Goel A, Ramakrishna B, Zachariah U, et al. What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors. Indian J Med Res. 2019;149:468–78.
Goel A, Madhu K, Zachariah U, et al. A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India. Indian J Med Res. 2013;137:922–7.
Mackie I, Eapen CE, Neil D, et al. Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 deficiency. Dig Dis Sci. 2011;56:2456–65.
Goel A, Alagammai PL, Nair SC, et al. ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension. Indian J Gastroenterol. 2014;33:355–63.
George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371:654–66.
Goel A, Raghupathy V, Amirtharaj GJ, et al. ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension. Indian J Gastroenterol. 2017;36:380–9.
Goel A, Ramakrishna B, Muliyil J, et al. Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis. Dig Dis Sci. 2013;58:179–87.
Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol. 1987;82:1130–3.
Koot BGP, Alders M, Verheij J, Beuers U, Cobben JM. A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension. J Hepatol. 2016;64:974–7.
Vilarinho S, Sari S, Yilmaz G, et al. Recurrent recessive mutation in DGUOK causes idiopathic non-cirrhotic portal hypertension. Hepatology. 2016;63:1977–86.
Goel A, Elias JE, Eapen CE, Ramakrishna B, Elias E. Idiopathic non-cirrhotic intrahepatic portal hypertension (NCIPH)—newer insights into pathogenesis and emerging newer treatment options. J Clin Exp Hepatol. 2014;4:247–56.
Chapla A, Mruthyunjaya MD, Asha HS, et al. Maturity onset diabetes of the young in India – a distinctive mutation pattern identified through targeted next-generation sequencing. Clin Endocrinol. 2015;82:533–42.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Baioumy SA, Fouad SH, Abdalgeleel SA, Baiomy AA, Sallam DE, Taha SI. Mannose-binding lectin serum levels and (Gly54asp) gene polymorphism in recurrent aphthous stomatitis: a case-control study. Int J Immunopathol Pharmacol. 2021;35:20587384211064456.
Carmolli M, Duggal P, Haque R, et al. Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent cryptosporidium infections in young children. J Infect Dis. 2009;200:1540–7.
Moreto A, Fariñas-Alvarez C, Puente M, et al. Mannose-binding lectin gene variants and infections in patients receiving autologous stem cell transplantation. BMC Immunol. 2014;15:17.
Lotta LA, Tuana G, Yu J, et al. Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. J Thromb Haemost. 2013;11:1228–39.
Monika S, Frank R, Anika W, et al. Rare variants in the ADAMTS13 von Willebrand factor–binding domain contribute to pediatric stroke. Circulation: Cardiovascular Genetics. Ame Heart Assoc. 2016;9:357–67.
Dash SC, Bhuyan UN, Dinda AK, et al. Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int. 1997;52:482–5.
Turner NA, Moake J. Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis. PLoS ONE. 2013;8: e59372.
Omanwar S, Rizvi MR, Kathayat R, et al. A rabbit model of non-cirrhotic portal hypertension by repeated injections of E. coli through indwelling cannulation of the gastrosplenic vein. Hepatobiliary Pancreat Dis Int. 2004;3:417–22.
Foldi I, Tornai T, Tornai D, et al. Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. Liver Int. 2017;37:1023–31.
Karrar A, Hariharan S, Malik K, et al. The role of mannan binding lectin pathway in non-alcoholic fatty liver disease (NAFLD): 573. Am J Gastroenterol. 2014;109:S168.
Eapen CE, Elias JE, Mackie I, Elias E. Prognostic significance of von Willebrand factor in cirrhosis: a possible mechanism. Hepatology. 2013;58:1189.
Kokame K, Matsumoto M, Soejima K, et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A. 2002;99:11902–7.
Funding
We received funds from Department of Science and Technology, Government of India (EMR/ 2015/000570).
Author information
Authors and Affiliations
Contributions
RA, AC, UZ, EE, JJ, KAB, SCN, NT, CEE and AG contributed to the study concept and design. UZ, AG and CEE recruited the patients and obtained informed consent. RA, KP, AC, BV, DD, JJ, KAB, SCN and NT performed the laboratory experiments. TAK and BR contributed to the pathology part. All were involved in data collection, interpretation and conclusion, preparation of the manuscript, critical revision and review of the manuscript and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
RA, KP, AC, BV, UZ, EE, TAK, DD, JJ, KAB, SCN, NT, BR, CEE and AG declare no competing interests.
Consent to participate
Obtained from all study participants.
Ethics statement
The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.
Disclaimer
The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Aaron, R., Premkumar, K., Chapla, A. et al. Focused panel sequencing points to genetic predisposition in non-cirrhotic intrahepatic portal hypertension patients in India. Indian J Gastroenterol 43, 434–442 (2024). https://doi.org/10.1007/s12664-023-01454-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-023-01454-5